Literature DB >> 8922640

Subcloning of three osteoblastic cell lines with distinct differentiation phenotypes from the mouse osteoblastic cell line KS-4.

T Yamashita1, H Ishii, K Shimoda, T K Sampath, T Katagiri, M Wada, T Osawa, T Suda.   

Abstract

Three distinct osteoblastic cell lines (KS418, KS460, and KS483) were subcloned from the mouse osteoblastic KS-4 cells, which possessed the abilities not only to differentiate into mature osteoblasts, but also to support osteoclast differentiation in coculture with spleen cells. The order of the magnitude of the basal alkaline phosphatase (ALP) activity was KS483 > KS418 > KS460. KS483 cells were also more differentiated than KS418 and KS460 in terms of ALP activity and osteocalcin production, when cultured in growth medium containing 10% fetal bovine serum. In long-term culture, KS418 and KS483 apparently differentiated into mature osteoblasts and formed calcified nodules without addition of beta-glycerophosphate. Electron microscopic analysis demonstrated that calcification occurring in the nodules was initiated in the matrix vesicles as observed in bone formation in vivo. Nodule formation and mineral deposition occurred simultaneously in the presence of beta-glycerophosphate, but the former always preceded the latter without addition of beta-glycerophosphate. In contrast, KS460 cells did not show time-dependent increases of ALP activity, type I collagen expression and osteocalcin production, which were induced by treatment with recombinant osteogenic protein-1 (OP-1). The three cell lines similarly supported osteoclast differentiation in coculture with spleen cells in response to 1,25-dihydroxyvitamin D3. These results indicate that the three cell lines subcloned from the original KS-4 cells represent phenotypically distinct osteoblasts during osteoblast differentiation, but are equipped similarly with the capacity to support osteoclast differentiation. The subcloned cells of the KS-4 series may provide useful systems in which to study osteoblast differentiation and function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922640     DOI: 10.1016/s8756-3282(96)00255-4

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway.

Authors:  Z C Dang; C W G M Lowik
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

2.  Entpd5 is essential for skeletal mineralization and regulates phosphate homeostasis in zebrafish.

Authors:  Leonie F A Huitema; Alexander Apschner; Ive Logister; Kirsten M Spoorendonk; Jeroen Bussmann; Chrissy L Hammond; Stefan Schulte-Merker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-12       Impact factor: 11.205

3.  Molecular biology of bone remodelling.

Authors:  Nadia Rucci
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

4.  Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways.

Authors:  Carola Krause; Olexandr Korchynskyi; Karien de Rooij; Stella E Weidauer; David J J de Gorter; Rutger L van Bezooijen; Sarah Hatsell; Aris N Economides; Thomas D Mueller; Clemens W G M Löwik; Peter ten Dijke
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

5.  Fatty acids derived from royal jelly are modulators of estrogen receptor functions.

Authors:  Paraskevi Moutsatsou; Zoi Papoutsi; Eva Kassi; Nina Heldring; Chunyan Zhao; Anna Tsiapara; Eleni Melliou; George P Chrousos; Ioanna Chinou; Andrey Karshikoff; Lennart Nilsson; Karin Dahlman-Wright
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

6.  Ter94/VCP is a novel component involved in BMP signaling.

Authors:  Zhao Zeng; David J J de Gorter; Maria Kowalski; Peter ten Dijke; Osamu Shimmi
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

7.  Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.

Authors:  Maarten van Dinther; Juan Zhang; Stella E Weidauer; Verena Boschert; Eva-Maria Muth; Achim Knappik; David J J de Gorter; Puck B van Kasteren; Christian Frisch; Thomas D Mueller; Peter ten Dijke
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

8.  Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.

Authors:  Rutger L van Bezooijen; Bernard A J Roelen; Annemieke Visser; Lianne van der Wee-Pals; Edwin de Wilt; Marcel Karperien; Herman Hamersma; Socrates E Papapoulos; Peter ten Dijke; Clemens W G M Löwik
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

9.  Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva.

Authors:  Songting Shi; Jie Cai; David J J de Gorter; Gonzalo Sanchez-Duffhues; Dwi U Kemaladewi; Willem M H Hoogaars; Annemieke Aartsma-Rus; Peter A C 't Hoen; Peter ten Dijke
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.